Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ewelina Zakrzewska"'
Autor:
Joanna Bartosińska, Ewelina Zakrzewska, Dorota Raczkiewicz, Joanna Purkot, Anna Michalak-Stoma, Małgorzata Kowal, Dorota Krasowska, Grażyna Chodorowska, Krzysztof Giannopoulos
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
Psoriasis is a chronic inflammatory disease mediated by T cell immunity. Programmed death 1 (PD-1), a coinhibitory receptor, plays an important role in immune regulation and maintaining peripheral tolerance. The aim of the study was to compare the ex
Externí odkaz:
https://doaj.org/article/b4d66bf008c84a6ebadaf619a24bd317
Autor:
Maciej Zakrzewski, Ewelina Zakrzewska, Paweł Kiciński, Sylwia Przybylska-Kuć, Andrzej Dybała, Wojciech Myśliński, Jolanta Pastryk, Tomasz Tomaszewski, Jerzy Mosiewicz
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166725 (2016)
Obstructive sleep apnoea (OSA) induces thrombophilia and reduces fibrinolysis. Alpha-2-antiplasmin (a-2-AP) and plasminogen activator inhibitor 1 (PAI-1) are major inhibitors of the fibrinolytic system. Increased concentrations of these factors are a
Externí odkaz:
https://doaj.org/article/d345775058de4143a58f6f9fcdac238c
Autor:
Krzysztof Giannopoulos, Paulina Wlasiuk, Elżbieta Starosławska, Ewelina Zakrzewska, Joanna Purkot, Agnieszka Karczmarczyk
Publikováno v:
Journal of Transfusion Medicine. 12:101-108
Background. Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia in adults with highly heterogeneous clinical course of the disease. Currently available prognostic factors are not fully efficient in predicting the course of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::385a6c9067359fc3af26bdf17e5c8bc5
https://doi.org/10.5603/jtm.2019.0006
https://doi.org/10.5603/jtm.2019.0006
Autor:
Bartłomiej Barczyński, Karolina Frąszczak, Iwona Wertel, Ewelina Zakrzewska, Małgorzata Zdunek, Justyna Szumiło, Jan Kotarski
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 30(7)
Luteinizing hormone-releasing hormone receptor (LHRHR) expression has been reported in various cancers, including endometrial neoplasms. Thus, LHRHR provides a potential point for therapeutic approach using LHRH analogs as carrier molecules for chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0b97532cf861f8bf373d309febe05c
https://pubmed.ncbi.nlm.nih.gov/35777983
https://pubmed.ncbi.nlm.nih.gov/35777983
Autor:
Agata Chudzik, Dorota Suszczyk, Anna Pawłowska, Monika Bilska, Ewelina Zakrzewska, Iwona Wertel, Marek Gogacz
Publikováno v:
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology
Journal of Oncology
Ovarian cancer (OC) is usually diagnosed at an advanced stage and is related with poor prognosis. Despite numerous studies, the pathogenesis of OC is still unknown. Recent studies indicate the role of the immune system in the development and spread o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f025c3411af85a431fb16d4e1c3f986b
https://doaj.org/article/c7d97869ee7c4e9fbcac2240217dca3a
https://doaj.org/article/c7d97869ee7c4e9fbcac2240217dca3a
Autor:
Dorota Krasowska, Joanna Purkot, Anna Michalak-Stoma, Ewelina Zakrzewska, Grażyna Chodorowska, Krzysztof Giannopoulos, Joanna Bartosińska, Małgorzata Kowal
Publikováno v:
Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii
Introduction Psoriasis with and without arthritis have common immunological mechanisms which among others involve the interactions between cytokines produced by T cells, including Th1, Th17 and Th22. Although quite a lot is known about psoriasis path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ff196ddad2caf2b7d3e4181f823469
http://europepmc.org/articles/PMC6130132
http://europepmc.org/articles/PMC6130132
Publikováno v:
Folia Histochemica et Cytobiologica. 55:95-106
Cytogenetic lesions do not completely explain clinical heterogeneity of chronic lymphocytic leukemia (CLL). The 2016 revision of the World Health Organization classification 2008 indicated that molecular lesions of TP53, NOTCH1, SF3B1 and BIRC3 have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abfa5255364b171ff56f9c0acd94d970
https://doi.org/10.5603/fhc.a2017.0019
https://doi.org/10.5603/fhc.a2017.0019
Autor:
Krzysztof Giannopoulos, Joanna Purkot, Ewelina Zakrzewska, Dorota Raczkiewicz, Dorota Krasowska, Joanna Bartosińska, Małgorzata Kowal, Anna Michalak-Stoma, Grażyna Chodorowska
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
Mediators of Inflammation
Mediators of Inflammation
Psoriasis is a chronic inflammatory disease mediated by T cell immunity. Programmed death 1 (PD-1), a coinhibitory receptor, plays an important role in immune regulation and maintaining peripheral tolerance. The aim of the study was to compare the ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec8eb5ac23bc12129c5bca2bef6145d7
https://doi.org/10.1155/2017/5385102
https://doi.org/10.1155/2017/5385102
Autor:
Joanna Bartosińska, Joanna Purkot, Dorota Raczkiewicz, Dorota Krasowska, Maria Majdan, Ewelina Zakrzewska, Krzysztof Giannopoulos, Anna Król, Grażyna Chodorowska
Publikováno v:
Polish Archives of Internal Medicine.
INTRODUCTION Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are characterized by chronic inflammatory processes mediated by proinflammatory cytokines that affect the synovial lining. Programmed death 1 (PD‑1) is a critical regulator of T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b920958577fffbbd8a36c088da56f0e
https://doi.org/10.20452/pamw.4137
https://doi.org/10.20452/pamw.4137
Autor:
Maciej, Putowski, Marta, Podgórniak, Marta, Piróg, Joanna, Knap, Joanna, Zaleska, Joanna, Purkot, Jacek, Zawiślak, Ewelina, Zakrzewska, Agnieszka, Karczmarczyk, Paulina, Własiuk, Edyta, Subocz, Krzysztof, Giannopoulos
Publikováno v:
Polish archives of internal medicine. 127(4)
INTRODUCTION Currently available prognostic factors determining the course of chronic lymphocytic leukemia (CLL) are not fully efficient, especially for newly diagnosed patients. Investigation of molecular changes may help clarify the reasons for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0fce6a7736299ab33f41125196154bc5
https://pubmed.ncbi.nlm.nih.gov/28424451
https://pubmed.ncbi.nlm.nih.gov/28424451